Stephen Hartman

AbbVie Inc.

Steve Hartman leads the Bioassay Development group at the AbbVie site in Redwood City, CA. He received his Ph.D. in Cellular and Molecular Biology from Yale University. He then joined the bioassay group at PDL BioPharma, which created the spin-off company Facet Biotech, which was acquired by Abbott Laboratories, which then founded AbbVie as a separate biopharmaceutical company. Steve’s group specializes in the innovation, development, qualification, transfer, and maintenance of cell-based and non-cell-based binding and functional potency assays for product release, stability, and characterization testing. He has worked in the bioassay field for over 15 years.